Navigation Links
Portola Pharmaceuticals Presents Positive Phase I Data of Its ADP,Receptor Antagonist at the American College of Cardiology

formulation and a single ascending dose study with the IV formulation. Based on positive results from these studies, Portola intends to initiate its Phase II program in 2007.

About Portola Pharmaceuticals, Inc.

Portola Pharmaceuticals, Inc. is a private biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapeutics for acute and chronic cardiovascular and vascular disease. Portola is currently developing two clinical stage antithrombotics. Portola's lead compound, PRT054021, is an oral Factor Xa inhibitor for the prevention of venous thromboembolism after orthopedic surgery, for stroke prevention in patients with atrial fibrillation, and for secondary prevention of myocardial infarction (MI) and stroke. Portola's second compound, PRT060128, is an oral and intravenous ADP receptor antagonist for patients with acute coronary syndrome, for the prevention of cardiovascular events in patients undergoing percutaneous coronary intervention and for secondary prevention of MI and stroke.

CONTACT: Ember Garrett of Porter Novelli Life Sciences, +1-619-849-5383,or , for Portola Pharmaceuticals egarrett@pnlifesciences.com

Web site: http://www.portola.com/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
3. Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies

Post Your Comments:
(Date:11/25/2009)...WYORK,Nov.25/PRNewswire/--Reportlinker.comannounce...ogue: ,, IntranasalDrugDelivery-USMarketTrends...7/Intranasal-Drug-Delivery---US-Market-Trends--Ana...tiswitnessinganexpansionoftherapeuticapplicationsf...othedeliveryofsystemictherapeuticdrugs.Thefutureof...
(Date:11/25/2009)...AMINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-FirstCal...HIN),aleadinginnovatorandprovideroflessinvasive,mi...izingthetreatmentofadvancedheartfailure,todayannou...tthe21stAnnualPiperJaffrayHealthCareConferenceat8:...eingheldattheNewYorkPalaceHotel,December1-2. ,,...
(Date:11/24/2009)...THESDA,Md.,Nov.24/PRNewswire-Asia/--ChindexInterna...ependentAmericanproviderofWestern,healthcareproduc...nouncedthattheCompanywillattendthe21stAnnualPiperJ...ember1-2,2009,atthe,NewYorkPalaceHotel. , Man...uesday,December1,2009,andholdone-on-onemeetingsth...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 1Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 2Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 3Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 4Pro Dex Inc Announces Fiscal 2009 Fourth Quarter Financial Results Conference Call and Webcast 56874 1Pro Dex Inc Announces Fiscal 2009 Fourth Quarter Financial Results Conference Call and Webcast 56874 2The 231 Stay Healthy Secret Whole Body Cleanse 28TM 29 from Enzymatic Therapy 56870 1The 231 Stay Healthy Secret Whole Body Cleanse 28TM 29 from Enzymatic Therapy 56870 2
...UBLIN, Calif., Dec. 8 SuperGen Inc. (Nasdaq: S...iscovery and development of novel cancer therapies...or, SGI-1776, is effective both in vitro and in vi...ukemia (ALL) (Abstract #1922) . This research wa...ican Society of Hematology. , , In a poster p...
...RINCETON, N.J., Dec. 8 Medarex, Inc. (Nasdaq:, M...tudy for MDX-1401, a,second-generation non-fucosyl...r for activated lymphocytes that is present on the...l as other CD30-expressing cancers. MDX-1401,demon...in cell lines when,compared to MDX-060. The improv...
Other Medicine Technology:SuperGen's PIM Kinase Inhibitor, SGI-1776, Effective in Pre-Clinical Models of Acute Lymphoblastic Leukemia 2SuperGen's PIM Kinase Inhibitor, SGI-1776, Effective in Pre-Clinical Models of Acute Lymphoblastic Leukemia 3Medarex Announces Enhanced Activity Data with Second Generation Anti-CD30 Antibody for Malignant Lymphoma 2Medarex Announces Enhanced Activity Data with Second Generation Anti-CD30 Antibody for Malignant Lymphoma 3
(Date:11/27/2009)...ings has announced that it has become a national s...gest nonprofit organizations dedicated to arthriti... Delray Beach, FL (Vocus) November..., a company specializing in the marketing and reta...as announced today that is has become a national s...
(Date:11/27/2009)... bilingual coloring books designed for children ag...nity to educate - inform parents and children alik...inosuars to ABC,S and a host of other topics. , ...ember 27, 2009 -- Today’s children have enou...any hour of the day, but one of the oldest and sim...
(Date:11/26/2009)...mericans living with diabetes will nearly double, ...on in 2034. Over the same period, spending on diab...to $336 billion, even with no increase in the prev...sity of Chicago report in the December issue of D...es covered by Medicare will rise from 8.2 million ...
(Date:11/26/2009)... of the Live Life Again Center, a practice offerin...wing number of physicians who are taking advantag...th individuals who are interested in surgical weig... is utilizing Facebook to share before-and-after p...community. , Dallas, TX (...
(Date:11/25/2009)...e/--TheBartleHallConventionCenterwilltemporarilybe...KansasCityhoststhelatestinaseriesofmassivefreeclin...asthepotentialtobethebiggestoneyet,becauseitwillex...insteadofoveraweekend,"SheriWood,executivedirector...tionalAssociationofFreeClinics(NAFC). ,, Atprev...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Kansas City Prepares for Largest Free Health Clinic 2
...Live, a not for,profit corporation, received a set...ts fight against the FDA on behalf of terminal can... will immediately file an,appeal in the 6th Circui...ongress needs,to wake up and hold hearings immedia...
...ology to Install Milestone Unit at ...v. 26 ZONARE Medical Systems, a developer of,prem... Society of North,America (RSNA) Annual Congress, ...ter. The Center is one of the most,respected cance...
...ics,Incorporated (NYSE: DGX ), the nation,s leadi... services, announced that it is scheduled to speak...ference at the Merrill,Lynch Headquarters in New Y...the company will reiterate its 2007 guidance for,r...
...tive herbicide tolerant systems and ...IM, Germany, Nov. 26 Bayer CropScience AG, Mertec...t they have entered into a,longterm collaboration ...et with the opportunity to expand to other,soybean...
...re not the best for them, study says , , M...rd of prostate cancer patients may receive treatme...y are already having with urinary, bowel or sexual...r favors a particular type of treatment, according...
...,Think About Their Drink, SOUTH BEND, Ind., Nov....winners selected in the Think About Your ... nationwide., WHAT: The Adams family en...ion campaign, the nation,s milk processor...
Other Medicine News:Health News:CareToLive Reports: The FDA Fiddles While 30,000 Men Burn 2Health News:CareToLive Reports: The FDA Fiddles While 30,000 Men Burn 3Health News:ZONARE Surpasses 1000th Worldwide z.one Ultrasound System Shipment 2Health News:ZONARE Surpasses 1000th Worldwide z.one Ultrasound System Shipment 3Health News:Quest Diagnostics to Speak at the Merrill Lynch Health Services Investor Conference 2Health News:Bayer CropScience, Mertec and M.S. Technologies to Co-Develop New Soybean Trait Products 2Health News:Bayer CropScience, Mertec and M.S. Technologies to Co-Develop New Soybean Trait Products 3Health News:Prostate Cancer Treatments Often Compound Existing Health Problems 2Health News:Prostate Cancer Treatments Often Compound Existing Health Problems 3Health News:Prostate Cancer Treatments Often Compound Existing Health Problems 4Health News:South Bend Area Family Wins Nationwide got milk? Contest 2Health News:South Bend Area Family Wins Nationwide got milk? Contest 3
Dual Channel Airways
Berman Airways
Soft Clear Guedel with Color Code Individually Bagged Oropharyngeal Airways
Color Coded Berman Oropharyngeal Airways - 50/Bag
Medicine Products: